Berger, M R <br/><br/>
Hexadecylphosphocholine differs from conventional cytostatic agents.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  1993 
 - 541-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0171-5216 
<br/><br/><label>Standard No.: </label>10.1007/BF01686464  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Antiviral Agents--pharmacology<br/>Chromatography, High Pressure Liquid<br/>DNA, Viral--drug effects<br/>Dose-Response Relationship, Drug<br/>Herpes Simplex--drug therapy<br/>Mammary Neoplasms, Experimental--drug therapy<br/>Methylnitrosourea<br/>Nucleotides--metabolism<br/>Phosphorylcholine--analogs & derivatives<br/>Rats<br/>Rats, Sprague-Dawley<br/>Simplexvirus--drug effects<br/>Vesicular stomatitis Indiana virus--drug effects<br/>Virus Diseases--drug therapy<br/>Virus Replication--drug effects